Who is speaking

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Jenny Clark at j.clark@oxfordglobal.co.uk

2015 Speakers

  • Dina Anderson
    Senior Principal Scientist, Syntaxin
  • Andreas Baumann
    Director and Principal Scientific Expert Biologics, Bayer
  • Stanislas Blein
    Director and Head Antibody Engineering, Biologics Research, Glenmark Pharmaceuticals
  • Jonny Finlay
    Director, Protein Discovery and Optimisation, Pfizer
  • Nicolas Fischer
    Head of Research, NovImmune
  • Stefan Geschwindner
    Principal Scientist, AstraZeneca
  • Steffen Hartmann
    Global Head Protein Developability, Novartis
  • Alistair Henry
    Director, Structural Biology and Biophysics, UCB
  • Guy Hermans
    Research Fellow, Ablynx
  • Rob Howes
    Associate Director, HTS, Antibody Discovery and Protein Engineering, MedImmune
  • John Kawooya
    Director, Biologics Optimization, Discovery Research, Amgen
  • Roman Kischel
    Principal Scientist, Amgen
  • Laura Lin
    Director, Biophysics, Analytics and Bioconjugation, Pfizer
  • Lorenz Mayr
    Vice President, Global Head Reagents and Assay Development, AstraZeneca
  • Brian McGuinness
    VP Discovery, Crescendo Biologics
  • Ralph Minter
    Fellow, Antibody Discovery and Protein Engineering, MedImmune
  • Jennifer Nemeth
    Associate Director, Biologics Discovery Program Leader, Janssen Research and Development
  • Crystal Sung
    Scientific Director, Sanofi
  • Annelise Vuidepot
    Head of Protein Science, Immunocore